(Q48285033)

10 February 2018

editorial

0 references

title

Improved, personalized treatment of glioma necessitates long-term follow-up of cognitive functioning (English)

1 reference

10 February 2018

1

Jaap C Reijneveld

1 reference

10 February 2018

Martin Klein

2

object named as

Martin Klein

1 reference

10 February 2018

author name string

Martin Jb Taphoorn

3

1 reference

10 February 2018

Tjeerd J Postma

4

1 reference

10 February 2018

Jan J Heimans

5

1 reference

10 February 2018

publication date

1 November 2012

1 reference

10 February 2018

published in

Pharmacogenomics

1 reference

10 February 2018

volume

13

1 reference

10 February 2018

issue

15

1 reference

10 February 2018

page(s)

1667-1669

1 reference

10 February 2018

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

Cognitive deficits in adult patients with brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

The measurement of cognitive functioning in low-grade glioma patients after radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

Cognitive functioning in long-term survivors of high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

Surviving glioblastoma for more than 5 years: the patient's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.12.172

21 January 2018

Identifiers

DOI

10.2217/PGS.12.172

1 reference

10 February 2018

1 reference

10 February 2018